Standout Papers
Citation Impact
Citing Papers
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
Catheter Ablation Versus Antiarrhythmic Drugs for Atrial Fibrillation
2008
Effect of Clopidogrel Added to Aspirin in Patients with Atrial Fibrillation
2009 Standout
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary
2014 Standout
Catheter Ablation versus Antiarrhythmic Drug Therapy for Atrial Fibrillation (CABANA) Trial: Study Rationale and Design
2018
Clinical Applications of Positron Emission Tomography in Cardiology: A Review
2004
Suppression of paroxysmal atrial tachyarrhythmias ? results of the SOPAT trial
2004
Aortic complications after bicuspid aortic valve replacement: long-term results
2002
A Clinical Prediction Model to Estimate Risk for 30-Day Adverse Events in Emergency Department Patients With Symptomatic Atrial Fibrillation
2010
Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach
2009 Standout
The Registry of the German Competence NETwork on Atrial Fibrillation: patient characteristics and initial management
2008
Amiodarone versus Sotalol for Atrial Fibrillation
2005
Ferric Carboxymaltose in Patients with Heart Failure and Iron Deficiency
2009 Standout
Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials
2003
Cellular pathophysiology of ischemic acute kidney injury
2011 Standout
Exercise Standards for Testing and Training
2013 Standout
Use of enalapril to facilitate sinus rhythm maintenance after external cardioversion of long-standing persistent atrial fibrillation Results of a prospective and controlled study
2003
Lenient versus Strict Rate Control in Patients with Atrial Fibrillation
2010
Differential Use of Warfarin for Secondary Stroke Prevention in Patients With Various Types of Atrial Fibrillation
2008
Is atrial fibrillation an inflammatory disorder?
2005
Carvedilol alone or in combination with digoxin for the management of atrial fibrillation in patients with heart failure?
2003
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Anticoagulation Therapy for Stroke Prevention in Atrial Fibrillation
2003
Outpatient Treatment of Recent-Onset Atrial Fibrillation with the “Pill-in-the-Pocket” Approach
2004
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
2008 Standout
Clinical predictors of atrial fibrillation recurrence in the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico–Atrial Fibrillation (GISSI-AF) trial
2010
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
2011 Standout
Local and systemic mechanisms linking periodontal disease and inflammatory comorbidities
2021 Standout
Rate or rhythm control in persistent atrial fibrillation?
2003
Biphasic energy selection for transthoracic cardioversion of atrial fibrillation. The BEST AF Trial
2007
Effects of sinus rhythm restoration in patients with persistent atrial fibrillation: a clinical, echocardiographic and hormonal study
2004
Long-term rhythm control of drug-refractory atrial fibrillation with “hybrid therapy” incorporating dual-site right atrial pacing, antiarrhythmic drugs, and right atrial ablation
2004
In Vivo Cardiac Electrophysiologic Effects of a Novel Diphenylphosphine Oxide IKur Blocker, (2-Isopropyl-5-methylcyclohexyl) Diphenylphosphine Oxide, in Rat and Nonhuman Primate
2006
Catheter ablation treatment in patients with drug-refractory atrial fibrillation: a prospective, multi-centre, randomized, controlled study (Catheter Ablation For The Cure Of Atrial Fibrillation Study)†
2005
GRADE guidelines: 3. Rating the quality of evidence
2011 Standout
Haemostatic Activity in Patients with Atrial Fibrillation Treated with Low-Molecular-Weight Heparin Before and After Electrical Cardioversion
2004
Twenty-five years in the making: flecainide is safe and effective for the management of atrial fibrillation
2010
Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial
2009
Rationale and current perspective for early rhythm control therapy in atrial fibrillation
2011
Prediction of left atrial appendage thrombi in non-valvular atrial fibrillation
2007
Atrial fibrillation
2011
Moderate physical exercise: a simplified approach for ventricular rate control in older patients with atrial fibrillation
2008
Clonal Analysis Unveils Self-Renewing Lineage-Restricted Progenitors Generated Directly from Hematopoietic Stem Cells
2013
Myocarditis
2011 Standout
Dabigatran versus Warfarin in Patients with Atrial Fibrillation
2009 Standout
Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations
2018 Standout
Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation
2007
Growth Differentiation Factor 11 Is a Circulating Factor that Reverses Age-Related Cardiac Hypertrophy
2013 Standout
Nonchannel drug targets in atrial fibrillation
2004
Are Atrial Fibrillation Patients Receiving Warfarin in Accordance with Stroke Risk?
2010
Antithrombotic Therapy in Atrial Fibrillation
2004
Clinician’s Guide to Cardiopulmonary Exercise Testing in Adults
2010 Standout
Valve-Sparing Aortic Root Replacement: Current State of the Art and Where Are We Headed?
2007
Radiofrequency Ablation vs Antiarrhythmic Drugs as First-line Treatment of Symptomatic Atrial Fibrillation
2005
Catheter Ablation for Atrial Fibrillation in Congestive Heart Failure
2004
Catheter Ablation for Atrial Fibrillation in Heart Failure Patients
2015
A Randomized Trial to Assess Catheter Ablation Versus Rate Control in the Management of Persistent Atrial Fibrillation in Heart Failure
2013
Physiology of Local Renin-Angiotensin Systems
2006 Standout
Surgical treatment of the dilated ascending aorta: when and how?
1999
Delayed rhythm control of atrial fibrillation may be a cause of failure to prevent recurrences: reasons for change to active antiarrhythmic treatment at the time of the first detected episode
2007
Antithrombotic Therapy in Valvular Heart Disease—Native and Prosthetic
2004
Risks and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation: An exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) trials
2006
Effect of rate or rhythm control on quality of life in persistent atrial fibrillation
2004
Catheter Ablation of Long‐Lasting Persistent Atrial Fibrillation: Clinical Outcome and Mechanisms of Subsequent Arrhythmias
2005
A randomized placebo-controlled trial of pre-treatment and short- or long-term maintenance therapy with amiodarone supporting DC cardioversion for persistent atrial fibrillation
2004
Targeting the renin-angiotensin-aldosterone-system in atrial fibrillation: a shift from electrical to structural therapy?
2005
Can atrial fibrillation with a coarse electrocardiographic appearance be treated with catheter ablation of the tricuspid valve-inferior vena cava isthmus? Results of a multicentre randomised controlled trial
2006
Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis
2002
Dronedarone for Maintenance of Sinus Rhythm in Atrial Fibrillation or Flutter
2007
Intravenous diltiazem is superior to intravenous amiodarone or digoxin for achieving ventricular rate control in patients with acute uncomplicated atrial fibrillation*
2009
Angiotensin-Converting Enzyme Inhibitors in Patients With Coronary Artery Disease and Absence of Heart Failure or Left Ventricular Systolic Dysfunction
2006
Augmented single‐unit muscle sympathetic nerve activity in heart failure with chronic atrial fibrillation
2011
Pharmacological rate control of atrial fibrillation
2004
Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited
2009 Standout
Antithrombotic Therapy in Atrial Fibrillation
2008
Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms
2010 Standout
2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation
2011
2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation
2011
Guidelines for the Early Management of Patients With Acute Ischemic Stroke
2013 Standout
Diagnosis and Management of the Metabolic Syndrome
2005 Standout
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult
2005 Standout
Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease
2010 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration
2015 Standout
2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2019 Standout
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
2011 Standout
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009
Lifetime Risk for Development of Atrial Fibrillation
2004
Guidelines for the Primary Prevention of Stroke
2014 Standout
2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons
2019 Standout
ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease: Executive Summary
2008 Standout
Forecasting the Future of Cardiovascular Disease in the United States
2011 Standout
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2006 Standout
Antiarrhythmic Drug Therapy for Atrial Fibrillation
2012
Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation
2019
Meta-analysis: Antithrombotic Therapy to Prevent Stroke in Patients Who Have Nonvalvular Atrial Fibrillation
2007 Standout
Long oligonucleotide microarrays for African green monkey gene expression profile analysis
2007 StandoutNobel
Worldwide Epidemiology of Atrial Fibrillation
2013 Standout
Atrial Remodeling and Atrial Fibrillation
2008
Safety and Efficacy of Enoxaparin Compared With Unfractionated Heparin and Oral Anticoagulants for Prevention of Thromboembolic Complications in Cardioversion of Nonvalvular Atrial Fibrillation
2004
Left Atrial Dysfunction in Patients With Atrial Fibrillation After Successful Rhythm Control for > 3 Months
2005
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
2008 Standout
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Omega-3 Polyunsaturated Fatty Acids Prevent Atrial Fibrillation Associated With Heart Failure but Not Atrial Tachycardia Remodeling
2007
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation—Executive Summary
2006
Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation
2015
Early Detection of Anthracycline Cardiotoxicity and Improvement With Heart Failure Therapy
2015 Standout
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation
2006
2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2008 Standout
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
Part 8: Adult Advanced Cardiovascular Life Support
2010 Standout
Works of T Kingma being referenced
Autologous peripheral blood stem cell transplantation in patients with relapsed lymphoma results in accelerated haematopoietic reconstitution, improved quality of life and cost reduction compared with bone marrow transplantation: the Hovon 22 study
2001
No difference in cardiac event-free survival between positron emission tomography-guided and single-photon emission computed tomography-guided patient management
2001
A Comparison of Rate Control and Rhythm Control in Patients with Recurrent Persistent Atrial Fibrillation
2002 Standout
Reduction of exercise-induced myocardial ischemia during add-on treatment with the angiotensin-converting enzyme inhibitor enalapril in patients with normal left ventricular function and optimal beta blockade
2001
Does flecainide regain its antiarrhythmic activity after electrical cardioversion of persistent atrial fibrillation?
2005
Rate control versus electrical cardioversion for atrial fibrillation: A randomised comparison of two treatment strategies concerning morbidity, mortality, quality of life and cost-benefit - the RACE study design.
2002
Improvement of left ventricular function after positron emission tomography based revascularization strategies in patients with hibernating myocardium. A prospective randomized comparison with single photon emission computed tomography
1997